Učitavanje...
Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab
Objective. The aim was to assess the efficacy of rituximab for the cutaneous manifestations of adult DM and JDM. Methods. Patients with refractory adult DM (n = 72) and JDM (n = 48) were treated with rituximab in a randomized placebo-phase-controlled trial [either rituximab early drug (week 0/1) or...
Spremljeno u:
| Izdano u: | Rheumatology (Oxford) |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854037/ https://ncbi.nlm.nih.gov/pubmed/27837048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kew396 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|